Health care stocks declined Tuesday afternoon, with the NYSE Health Care Index falling 2.1% and the Health Care Select Sector SPDR Fund (XLV) dropping 2.8%.
The iShares Biotechnology ETF (IBB) slumped 6%.
In corporate news, Beam Therapeutics (BEAM) shares tumbled past 17% after it reported a wider Q1 loss compared with a year earlier.
Philips (PHG) shares fell 5.5% after it reported flat Q1 adjusted earnings per share, while sales declined.
Viridian Therapeutics (VRDN) shares were down 7.4% after it reported a Q1 net loss of $0.87 per diluted share, widening from a loss of $0.59 a year earlier.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.